Condition: Restless Legs Syndrome (RLS) · Sponsor: Noctrix Health, Inc.
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
This description comes directly from the study's public registry record.
Clinical Research Coordinator · 415-531-1578 · clinicalcoordinator@noctrixhealth.com
Always discuss trial participation with your own doctor first.
| Noctrix Health Headquarters | Pleasanton, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07675109